A Comparative Analysis of Ultrasound's Accuracy in Diagnosing HC Using Histopathology as Gold Standard

The study aims to evaluate the accuracy of ultrasound in diagnosing hepatocellular carcinoma (HCC), using histopathology as the gold standard. It addresses HCC's high global incidence and the utility of ultrasound as a non-invasive, cost-effective screening tool. Despite ultrasound's accessibility, its diagnostic limitations necessitate further investigation to improve clinical outcomes.

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Hepatocellular Carcinoma Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Medcare International Hospital

Guiranwala, Punjab Province, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Clinically suspected liver cancer patients undergoing ultrasound examination.
Patients undergoing histopathological examination (liver biopsy or resection) for definitive diagnosis.

Exclusion criteria

Patients with history of liver cancer treatment or inadequate data."

Treatment and study plan

Group 1

Radiation

To determine the sensitivity of ultrasound in detecting HCC

Primary outcomes

ultrasound

Time frame: 12 Months

Sensitivity and Specificity analysis of Ultrasound as diagnostic tool, with histopathology as gold standard.

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Official study title

A Comparative Analysis of Ultrasound's Accuracy in Diagnosing Hepatocellular Carcinoma Using Histopathology as Gold Standard

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Dec 27, 2024
Registry last updated: Dec 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Active, not recruiting